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Abstract 1 
From our in-house microbial genome database of secondary metabolite producers, we identified a 2 
candidate biosynthetic gene cluster for desertomycin from Streptomyces nobilis JCM4274.  We report 3 
herein the cloning of the 127-kb entire gene cluster for desertomycin biosynthesis using bacterial artificial 4 
chromosome (BAC) vector.  The entire biosynthetic gene cluster for desertomycin was introduced in the 5 
heterologous host, Streptomyces lividans TK23, with an average yield of more than 130 mg L−1. 6 
    7 
Screening for bioactive microbial secondary metabolites has been carried out for more than 70 years.  Although the 1 
findings of bioactive natural products have resulted in great benefits to humankind, the rate of discovery of skeletally-2 
novel compounds from microorganisms has significantly decreased over time (ref. 1, 2).  Recent advances in 3 
sequencing technology gave us massive genome sequences, including biosynthetic gene clusters for microbial 4 
secondary metabolites, in public databases.  However, most of those biosynthetic gene clusters remain unidentified to 5 
date.  For the efficient discovery of novel compounds from such unused biosynthetic gene clusters, accumulation of 6 
datasets for the identified biosynthetic gene clusters, which can be used as reference databases such as MiBIG (ref. 3) 7 
and DoBuiscuit (ref. 4), is important.  To accomplish this purpose, heterologous expression of the entire biosynthetic 8 
gene clusters is the most reliable way to characterize the exact biosynthetic gene clusters.  We have determined 9 
bacterial genome sequences of over 100 microorganisms including actinomycetes, Pseudomonas, Burkholderia, 10 
Bacillus, etc., for genome mining of biosynthetic gene clusters.  In this genome database, we focused on the YM-11 
216391 producing-Streptomyces nobilis JCM4274, because its genome contains not only the biosynthetic gene cluster 12 
for YM-216391, but also several others for secondary metabolites including the candidate gene of desertomycin. 13 
Desertomycins have been reported to show antifungal activities (ref. 5) and are members of marginolactone 14 
compounds, which contain amino or guanidino groups, and possess a ring size of 31 carbon atoms or more, such as 15 
mathemycin, primycin and kanchanamycin (ref. 6).  The previous biosynthetic studies on desertomycin have only 16 
identified the last step of the biosynthesis catalyzed by DstH (ref. 7).  The amidinohydrolase homologue encoded by 17 
dstH catalyzes the conversion of de-amidination of desertomycin B to desertomycin A during post-PKS tailoring 18 
process.  Although the region encoding desertomycin biosynthesis was proposed in a previous study (ref. 7), the 19 
experimental validation of the entire biosynthetic gene cluster has not been examined due to the difficulties in cloning 20 
and transformation of such huge size DNA.  We have established a technique for the cloning and heterologous 21 
expression of large biosynthetic gene clusters for type-I PKS compounds using bacterial artificial chromosome (BAC) 22 
vectors and have succeeded in the heterologous production of mediomycin, neomediomycin (ref. 8), JBIR-156 (ref. 9) 23 
and quinolidomicin (ref. 10) whose biosynthetic gene clusters are 161, 183, 137 and 213 kbp in length, respectively.  24 
Here we report the identification of the entire biosynthetic gene cluster for desertomycin spanning 127 kb region. 25 
Based on the chemical structure of desertomycin A, we predicted its biosynthetic gene cluster.  The deduced 26 
biosynthetic gene cluster for desertomycin including nineteen genes which encode eight type-I polyketide synthases 27 
(PKSs), dstA1-A8, seven accessory enzymes, three transporters and a LuxR-family transcriptional regulator was found 28 
in S. novilis JCM4274 (Table S1).  The eight PKS genes are transcribed in one direction.  Deduced amino acid 1 
sequences of the eight PKSs (DstA1-A8) were compared with those of known type-I PKSs to predict their domain 2 
organizations (Figure S1).  The deduced gene products of the eight PKSs include twenty-one modules for 3 
decarboxylative chain-elongation reactions in addition to an acyl-carrier protein (ACP) located at N-terminus of DstA1.  4 
Genes, dstB and dstD, encoding arginine 2-monooxygenase and acyl-CoA ligase, respectively, which are responsible 5 
for the formation of a starter unit of polyketide synthase DstA1, 4-guanidinobutyryl-CoA, also lie in the biosynthetic 6 
gene cluster. (ref. 11).  A gene encoding an amide hydrolase, which acts at the second step in the biosynthesis of the 7 
starter unit, is responsible for conversion from 4-guanidinobutyramide to 4-guanidinobutyric acid, was not found in 8 
the biosynthetic gene cluster but the corresponding gene lies at a 6.5 Mb distance from the biosynthetic gene cluster.  9 
A discrete acyltransferase (AT) gene, dstE was also located in the biosynthetic gene cluster, which is responsible for 10 
the loading of 4-guanidinobutyryl-CoA onto the N-terminus ACP of DstA1.  Substrate specificity of AT domains in 11 
each module was also predicted by comparing their amino acid sequences.  The AT domains in module 2, 3, 4, 5, 8, 12 
9, 11, 14, 16, 17 and 20, and in module 1, 6, 7, 12, 13, 15, 18, 19 and 21 are specific for malonyl transferring domains, 13 
and methylmalonyl transferring domains, respectively (Figure S2) (ref. 12).  Surprisingly, the catalytic serine residue 14 
(-GHS-) was not conserved in the AT domain in module 10.  In addition, this AT domain is shorter than the other AT 15 
domains: the second conserved motif was deleted (Figure S2).  AT domain in module 10 might be categorized as 16 
dysfunctional domain (ref. 13).  Similar AT domains were reported in the biosynthetic gene cluster for gephyronic 17 
acid (module 2 and 4) (ref. 14), conglobatin (module 3) (ref. 15), and bengamide (module 3) (ref. 16).  These AT 18 
domains also do not contain the conserved serine residue in their active sites and are shorter than typical AT domain.   19 
These AT domains look like dysfunctional, but the chain-extension reaction is not terminated at the corresponding 20 
module thereafter the chain extension reaction might be continued to final module and the acyl chain is generated and 21 
released because desired macrolactone compounds were produced from these producers. The active site and the 22 
reaction mechanism in these shorter AT domains are still unclear.  Ketoreductase (KR) domains of each module were 23 
analyzed for prediction of stereochemical outcome of hydroxy groups.  The KR domains in module 5, 7, 10, 13, 15, 24 
18 and 19, and in module 1, 2, 3, 4, 6, 8, 9, 11, 12, 14, 16, 17, 20 and 21 are A types responsible for the L-configuration 25 
of hydroxy groups and B type for the D-configuration, respectively (Figure 2) (ref. 17).  The thioesterase (TE) domain 26 
resides in the C-terminus of DstA8, which releases the acyl intermediate from DstA8 then a carboxyl residue at C-1 27 
position of the acyl chain released would be regioselectively cyclized with a hydroxyl residue at C-41 position of the 28 
acyl chain. 1 
For the cloning and heterologous expression of the biosynthetic gene cluster, the BAC library of S. nobilis 2 
JCM4274 was constructed as previously described (ref. 18).  Partially BamHI-digested genome DNA fragments were 3 
cloned into BamHI site of an integrating BAC vector pKU518 (ref. 19).  BAC clones containing the entire biosynthetic 4 
gene cluster for desertomycin were selected by PCR screening with primers targeting the flanking region of the 5 
biosynthetic gene cluster.  After PCR screening, four desired clones were obtained from 1,536 clones in the BAC 6 
library and among these, pKU518JCM4274_P1_P1-M4, was introduced into S. lividans TK23.  The resulting 7 
transformant was cultivated in seed medium at 320 rpm, at 27 ˚C for 2 days.  Aliquots (450 µL) of pre-cultures were 8 
inoculated into 15 mL of 0.3 x BPS medium (ref. 20) and were cultured on a rotary shaker (180 rpm) at 27 ˚C for 5 9 
days.   10 
The culture extract was subjected to LC/MS and a novel peak showing UV absorption peak at 220 nm was detected 11 
in transformants (Figure 1).  The m/z of the new peak was found to be 1192.7577 (C61H110NO21+, [M+H]+: + 0.7 mmu) 12 
by HRMS analysis.  The product was identified as desertomycin A by comparison with an authentic standard.  13 
Desertomycin A was also detected from culture extracts of S. nobilis JCM4274.  The productivity of desertomycin A 14 
in the S. lividans TK23 transformant was 139 ± 29 mg L−1, while that of the original strain S. nobilis JCM4274 was 15 
only 28 ± 6 mg L−1.  The productivity of desertomycin A from transformants was higher than that of the original 16 
producing strain under the same cultivation conditions (Figure S3). 17 
Although the absolute stereochemistry of desertomycin A had been determined by Kishi et al (ref. 21), the 18 
stereochemistry of a methyl residue at C-32 was inconsistent with prediction by classification of KR domain (in module 19 
6), which is concerned with the stereochemistry at C-32 methyl residue.  In module 6, which corresponds to the 20 
biogenesis of the C-32 methyl group, we recognized an additional DH domain that may be dysfunctional.  Recently, 21 
a biochemical study on dysfunctional DH domains, NanDH1, NanDH5 and NigDH1, revealed that some dysfunctional 22 
DH domains have epimerization activity for -methyl groups (ref. 22).  Therefore, we considered that the 23 
stereochemical output at C-32 might come from the epimerizing activity of the dysfunctional DH domain in module 6.  24 
To confirm stereochemistry at C-32, we analyzed the relative configuration between C-32 and C-33 by the J-based 25 
configuration analysis (JBCA) (ref. 23) using vicinal 1H–1H (from DQF-COSY spectra) and long-range 1H–13C 26 
coupling constants (from J-resolved HMBC spectra) (ref. 24-27).  A large coupling constant value between H-31 and 27 
H-32 (3JH31-H32 = 10 Hz) revealed that they are in the anti orientation, while that between H-32 and H-33 was small 28 
(3JH32-H33 ~ 1.2 Hz) showing that they are in the gauche orientation (Figure S4).  The small coupling constant value 1 
between H-32 and C-33 (2JH32-C33 = ~ 0 Hz) was consistent with the anti orientation between H-32 and O-33.  In 2 
addition, the large coupling constant value between H (H-33) and CH3 (C-32; 3J33H-32CH3 = 6 Hz) indicates anti 3 
orientation between H (33-H) and CH3 (C-32).  Taking into consideration these results, when assuming the 4 
stereochemistry of C-33 as R* configuration, the configuration of C-32 is elucidated as S*.  These results support the 5 
reported stereochemistry, which proved the credibility of the inactive DH domain function to elucidate the absolute 6 
configuration of methyl residues on type-I PKS compounds.  Thus, stereochemistry of acyl intermediate bound to 7 
ACP in Module 21 was considered to be (6S, 7R, 8S, 9S, 14S, 15S, 18S, 19R, 23S, 25R, 27S, 29S, 30S, 31R, 32S, 33R, 8 
35S, 37S, 41S, 42R, 43R) and is illustrated as shown in Figure 2. 9 
In this study, we have identified the entire biosynthetic gene cluster for desertomycin by cloning and 10 
heterologous expression experiments.  The size of the inserted DNA in the BAC clone, pKU518JCM4274_P1_P1-11 
M4, was 181 kb which is sufficiently large to accommodate the entire biosynthetic gene cluster for 42-membered large 12 
macrolides, desertomycin (127 kb).  The production of desertomycin was confirmed in S. lividans TK23 despite of 13 
the absence of a gene encoding amide hydrolase in the BAC clone pKU518JCM4274_P1_P1-M4.  Therefore, it is 14 
likely that an endogenous gene product of amide hydrolase in the S. lividans TK23 (accession # EOY46468; hydrolase, 15 
262 aa) could complement the function for the hydrolysis of amide residue.  Accumulation of such experimental data 16 
of known compounds would be a clue for the production of compounds derived from unknown biosynthetic gene 17 
clusters and skeletally novel compounds by genome mining.   18 
Recently, a congener of desertomycins, desertomycin G was reported to exhibit anti-tuberculosis activity (ref. 19 
28).  Therefore, new desertomycin family compound is expected to show a variety of bioactivities and broaden the 20 
antibacterial spectrum.  Structural differences between desertomycin A and G are the presence of a double bond at C-21 
4 and a methyl group at C-24 positions of desertomycin A.  Nowadays, we develop the innovative technique “module 22 
editing”, by which we can produce desired derivatives of type-I PKS compounds.  By applying this technique, genetic 23 
modification of the type I PKS gene, dstA1-8, on the BAC clone employed as the template would lead to novel 24 
derivatives of desertomycins.  Heterologous expression of desertomycin A with a production yield of more than 100 25 
mg L−1 set the stage for the genetic engineering of polyketide synthases of desertomycin A on a BAC clone, 26 
pKU518JCM4274_P1_P1-M4, to produce novel desertomycin analogs. 27 
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Figure 1. (A) Structure of desertomycins A and G. The differences between the structures are shown by the 2 
dotted rectangles. (B)  HPLC chromatograms of authentic sample of desertomycin A (i), culture extracts 3 
from S. nobilis JCM4274 (ii) and S. lividans TK23 carrying pKU518JCM4274_P1_P1-M4 (iii) and S. 4 
lividans TK23 (iv).  Chromatograms were traced at 220 nm.  5 
 6 
 7 




































Figure 2. Proposed biosynthetic pathway by polyketide synthases encoded in dstA1-A8. 2 
KR domains of A1, A2 and B1 type are colored white, black and gray respectively.  A methyl group at C-3 
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